Complete financial analysis of Sibannac, Inc. (SNNC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sibannac, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Yaizu Suisankagaku Industry Co.,Ltd. (2812.T) Income Statement Analysis – Financial Results
- Tubacex, S.A. (0KD1.L) Income Statement Analysis – Financial Results
- Spenda Limited (SPX.AX) Income Statement Analysis – Financial Results
- Carnegie Wealth Management Nordiske Aktier (CMINOA.CO) Income Statement Analysis – Financial Results
- Hudson Executive Investment Corp. III (HIIIW) Income Statement Analysis – Financial Results
Sibannac, Inc. (SNNC)
About Sibannac, Inc.
Sibannac, Inc. operates as a media and management services company. It serves businesses with online marketing, advertising, sales tracking, management consulting, and other informational services. The company also provides accounting, and expense and labor management systems to assist in compliance in the regulated industry environment. Sibannac, Inc. is based in Phoenix, Arizona.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 434.00 | 6.42K | 157.31K | 255.06K | 55.50K | 0.00 | 523.68K | 0.00 | 0.00 | 207.32K | 288.04K | 1.07M |
Cost of Revenue | 208.00 | 2.50K | 100.29K | 205.14K | 46.03K | 0.00 | 453.30K | 0.00 | 0.00 | 23.22K | 60.56K | 159.05K |
Gross Profit | 226.00 | 3.92K | 57.02K | 49.92K | 9.47K | 0.00 | 70.38K | 0.00 | 0.00 | 184.10K | 227.48K | 914.78K |
Gross Profit Ratio | 52.07% | 61.03% | 36.25% | 19.57% | 17.06% | 0.00% | 13.44% | 0.00% | 0.00% | 88.80% | 78.98% | 85.19% |
Research & Development | 225.00 | 49.68K | 8.49K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 428.99K | 388.98K | 421.91K | 317.58K | 0.00 | 0.00 | 269.77K | 133.05K | 69.84K | 310.47K | 417.14K | 838.20K |
Selling & Marketing | 4.60K | 43.81K | 27.50K | 29.45K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 19.03K | 31.62K | 130.26K |
SG&A | 519.15K | 482.99K | 535.28K | 414.96K | 265.16K | 306.87K | 269.77K | 133.05K | 69.84K | 329.50K | 448.76K | 968.46K |
Other Expenses | -1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 519.38K | 532.67K | 543.77K | 414.96K | 265.16K | 306.87K | 276.00K | 133.05K | 69.84K | 329.50K | 448.76K | 968.46K |
Cost & Expenses | 519.59K | 535.17K | 644.05K | 620.10K | 311.20K | 306.87K | 729.29K | 133.05K | 69.84K | 352.72K | 509.32K | 1.13M |
Interest Income | 0.00 | 91.98 | 5.72K | 3.99K | 3.98K | 3.98K | 4.12K | 28.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 37.88K | 91.98K | 109.09K | 64.67K | 45.32K | 25.48K | 30.66K | 0.00 | 0.00 | 22.20K | 12.83K | 8.01K |
Depreciation & Amortization | 519.15K | 528.76K | 486.74K | 365.04K | 171.86K | 0.00 | 4.12K | 4.48M | 0.00 | 14.56K | 13.64K | 13.60K |
EBITDA | 135.89K | 9.44K | 29.90K | 3.99K | -251.72K | -306.87K | -132.55K | 2.11M | -69.84K | -130.84K | -207.64K | -40.07K |
EBITDA Ratio | 31,310.37% | -8,242.56% | -309.41% | -143.12% | -460.73% | 0.00% | -37.29% | 0.00% | 0.00% | -63.11% | -72.08% | -3.73% |
Operating Income | -519.15K | -528.76K | -486.74K | -365.04K | -255.70K | -306.87K | -199.38K | -2.37M | -69.84K | -145.40K | -221.27K | -53.68K |
Operating Income Ratio | -119,620.05% | -8,242.56% | -309.41% | -143.12% | -460.73% | 0.00% | -38.07% | 0.00% | 0.00% | -70.13% | -76.82% | -5.00% |
Total Other Income/Expenses | 98.01K | -82.53K | -79.20K | -60.68K | -41.35K | -21.50K | -151.64K | -2.27M | 0.00 | -22.20K | -12.83K | -8.01K |
Income Before Tax | -421.15K | -611.29K | -565.94K | -425.72K | -297.04K | -328.37K | -351.02K | -2.37M | -69.84K | -167.60K | -234.11K | -61.69K |
Income Before Tax Ratio | -97,038.02% | -9,529.10% | -359.76% | -166.91% | -535.22% | 0.00% | -67.03% | 0.00% | 0.00% | -80.84% | -81.28% | -5.75% |
Income Tax Expense | 0.00 | -18.86K | -486.74 | -62.81K | -171.86K | 0.00 | 32.77K | -2.24M | 210.95K | 0.00 | 0.00 | 0.00 |
Net Income | -421.15K | -592.96K | -565.94K | -363.27K | -297.04K | -328.37K | -351.02K | -2.37M | -280.79K | -167.60K | -234.11K | -61.69K |
Net Income Ratio | -97,038.02% | -9,243.29% | -359.76% | -142.43% | -535.22% | 0.00% | -67.03% | 0.00% | 0.00% | -80.84% | -81.28% | -5.75% |
EPS | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.20 | -0.06 | -0.03 | -0.05 | -0.01 |
EPS Diluted | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.20 | -0.06 | -0.03 | -0.05 | -0.01 |
Weighted Avg Shares Out | 84.23M | 77.98M | 26.22M | 16.13M | 16.13M | 16.13M | 17.53M | 12.13M | 4.94M | 4.99M | 4.99M | 4.99M |
Weighted Avg Shares Out (Dil) | 84.23M | 77.98M | 26.22M | 16.13M | 16.13M | 16.13M | 17.53M | 12.13M | 4.94M | 4.99M | 4.99M | 4.99M |
Sibannac, Inc. and Celebrity Television Personality William Henry Launch Groundbreaking Multimedia Community in Partnership with Industry Leading Monetization Innovator
Sibannac, Inc. Introduces Alternative Wellness Brand Cherryology
Sibannac, Inc. Provides New Shareholder Update
Sibannac, Inc. Launches the Campus Community and Details NASDAQ IPO Spin Off Program
Sibannac, Inc. Sets Goals for 2024
Sibannac, Inc. Provides Distribution and Formulation Updates for Its NOHO (R) Recovery Shot
Sibannac, Inc. to Enter into Manufacturing Agreement with Major Extraction Partner for Onsite Oil Production
Sibannac, Inc. Gearing up for Revenue Through Its White-Label Manufacturing, Wholesale Distribution and Opening of Its First Retail Location
Sibannac, Inc. Provides Update on Operations
Sibannac, Inc. Signs Heads of Terms Agreement with Allstar Health-Tyme Cannabis to Enter the Canadian Cannabis Retail Market
Source: https://incomestatements.info
Category: Stock Reports